Emotion Regulation and Cancer Caregiving

Sponsor
Stanford University (Other)
Overall Status
Completed
CT.gov ID
NCT06123416
Collaborator
U.S. National Science Foundation (U.S. Fed)
30
1
5.9
5.1

Study Details

Study Description

Brief Summary

The purpose of the study is to determine how the behaviors of cancer caregivers can impact patients.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Expressive Writing

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
30 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Emotion Regulation and Cancer Caregiving
Actual Study Start Date :
Jan 16, 2019
Actual Primary Completion Date :
Jul 15, 2019
Actual Study Completion Date :
Jul 15, 2019

Arms and Interventions

Arm Intervention/Treatment
Control Caregivers

Control participants will write about their daily and future tasks three times.

Behavioral: Expressive Writing
Caregivers complete three 20-min writing sessions in which they write about an assigned topic - emotional or non-emotional.

Expressive Writing Caregivers

Experimental participants will write about their thoughts and feelings about an emotionally difficult event three times.

Behavioral: Expressive Writing
Caregivers complete three 20-min writing sessions in which they write about an assigned topic - emotional or non-emotional.

Outcome Measures

Primary Outcome Measures

  1. Emotion Regulation Questionnaire [Baseline through 3 months post-intervention]

    Emotion regulation refers to the ways people influence which emotions they have, and how they experience and express these emotions. Participants will rate their habitual pursuit of pro-hedonic, contra-hedonic, pro-social, and impression management goals using the ERGS. The items will be rated on the same 7-point scale (1 = never; 7 = always).

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
All participants must:
  • Be 21 years or older

  • Have access to a computer with internet access

Patients must:
  • Be women

  • Have a diagnosis of breast cancer (non-recurrent)

Caregivers must be:

-The patient's caregiver (providing support to the patient)

Exclusion Criteria:
Participants must not be:

-Younger than 21 years

Patients must not:
  • Be men

  • Have a diagnosis other than breast cancer (non-recurrent)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stanford University Stanford California United States 94305

Sponsors and Collaborators

  • Stanford University
  • U.S. National Science Foundation

Investigators

  • Principal Investigator: Lameese Eldesouky, PhD, Stanford University
  • Study Director: James Gross, PhD, Stanford University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Stanford University
ClinicalTrials.gov Identifier:
NCT06123416
Other Study ID Numbers:
  • IRB-47800
First Posted:
Nov 8, 2023
Last Update Posted:
Nov 13, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Nov 13, 2023